FDA approves breakthrough drug to treat advanced pancreatic cancer
Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.
Useful takeaways from this story.
Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.